DYN insider trading
NasdaqGS HealthcareDyne Therapeutics, Inc.: insider trade history from SEC Form 4 filings.
About Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Company website: www.dyne-tx.com
DYN insider activity at a glance
FilingIQ tracks 880 insider transactions for DYN in filings since Jan 16, 2015. The most recent transaction is dated Sep 8, 2026.
Across the full history, 48 open-market purchases
and 505 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on DYN insider trades is 54.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest DYN Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for DYN?
- FilingIQ tracks 880 Form 4 insider transactions for DYN (Dyne Therapeutics, Inc.), covering filings from Jan 16, 2015 onwards. 17 of those are dated within the last 90 days.
- Are DYN insiders net buyers or net sellers?
- Across the full Form 4 history for DYN, 48 transactions (5%) were open-market purchases and 505 (57%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does DYN insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is DYN in?
- Dyne Therapeutics, Inc. (DYN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $2.54B.
Methodology & sources
Every DYN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.